Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitors. A case series and analysis of cases reported in the Spanish pharmacovigilance database
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Dermatology"
DOI: 10.1111/ijd.14658
Abstract: Bullous pemphigoid (BP) has been associated with dipeptidyl peptidase‐4 inhibitors (DPP4i). Clinical features, outcomes, and risk of BP for new DPP4i (linagliptin, saxagliptin, and alopgliptin) are not well established. Comparison of risk of BP appearance… read more here.
Keywords: peptidase inhibitors; associated dipeptidyl; pemphigoid associated; bullous pemphigoid ... See more keywords